WAL0921 | m-entrepreneurship.com

Product Name :
WAL0921

Search keywords :
uPAR

drugId :
null

Target Vo:
Urokinase plasminogen activator surface receptor

Target Vo Short Name :
PLAUR

Moa_Name:
Urokinase plasminogen activator surface receptor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Walden Biosciences Inc

Active Company_Name :
University Of Michigan

Active Indication_Name:
Renal Insufficiency, Chronic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Flotetuzumab In Vivo
Belantamab In Vivo
Cytochrome C Antibody: Cytochrome C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to Cytochrome C. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts